Cochrane Abstracts
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High‐dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation Versus Conventional Chemotherapy for Women With Early Poor Prognosis Breast Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer.
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer. Accessed January 15, 2025.
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer
High‐dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation Versus Conventional Chemotherapy for Women With Early Poor Prognosis Breast Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
ID - 432830
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
